Market News

    RSS Feed

Homology Medicines Inc. Launches as a Newly-Formed Genetic Medicines Company Founded Upon a Unique City of Hope Gene Editing and Gene Transfer Platform Technology

May 2, 2016 | DUARTE, Calif.–(BUSINESS WIRE)–City of Hope today announced that it has licensed its pioneering
AAV-based gene editing technology exclusively to Homology Medicines
Inc., a newly-formed genetic medicines company. A City of Hope lab led
by Saswati Chatterjee, Ph.D., developed the single platform technology
that enables both gene editing and gene therapy with a built-in in
vivo  … Read More